Baijin Life Science Holdings Limited Receivables

Baijin Life Science Holdings Limited posts a receivables of $60M as of March 2026. That compares with $110M in the prior-year period — down 45.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Baijin Life Science Holdings Limited's receivables was $110M. The latest reading is $60M — a 45.1% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Baijin Life Science Holdings Limited's financial statement story. At $60M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for MNNGF's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Baijin Life Science Holdings Limited's other metric pages and overview cover the third.